FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026702932> ?p ?o ?g. }

• W2026702932 endingPage "313" @default.
• W2026702932 startingPage "301" @default.
• W2026702932 abstract "CA: A Cancer Journal for CliniciansVolume 32, Issue 5 p. 301-313 ArticleFree Access A different perspective on breast cancer risk factors: Some implications of the nonattributable risk Herbert Seidman M.B.A, Herbert Seidman M.B.A Assistant Vice President for Epidemiology and Statistics of the American Cancer Society in New York, New YorkSearch for more papers by this authorSteven D. Stellman Ph.D, Steven D. Stellman Ph.D Assistant Vice President for Epidemiology of the American Cancer Society in New York, New YorkSearch for more papers by this authorMargaret H. Mushinski M.A, Margaret H. Mushinski M.A Senior Epidemiologic Research Associate of the American Cancer Society in New York, New YorkSearch for more papers by this author Herbert Seidman M.B.A, Herbert Seidman M.B.A Assistant Vice President for Epidemiology and Statistics of the American Cancer Society in New York, New YorkSearch for more papers by this authorSteven D. Stellman Ph.D, Steven D. Stellman Ph.D Assistant Vice President for Epidemiology of the American Cancer Society in New York, New YorkSearch for more papers by this authorMargaret H. Mushinski M.A, Margaret H. Mushinski M.A Senior Epidemiologic Research Associate of the American Cancer Society in New York, New YorkSearch for more papers by this author First published: September/October 1982 https://doi.org/10.3322/canjclin.32.5.301Citations: 86AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 American Cancer Society: Cancer Facts and Figures, 1982. New York, American Cancer Society Inc, 1982. 2 Lane-Claypon JE: A further report on cancer of the breast, with special reference to its associated antecedent conditions, in Reports of the Ministry of Health: Public Health and Medical Subjects No. 32. London, British Ministry of Health, 1926. 3 MacMahon B, Cole P, Brown J: Etiology of human breast cancer: a review. JNCI 50: 21– 42, 1973. 4 Wynder EL, MacCornack FA, Stellman SD: The epidemiology of breast cancer in 785 United States Caucasian women. Cancer 41: 2341– 2354, 1978. 5 Kelsey JL: A review of the epidemiology of human breast cancers. Epidemiol Rev 1: 74– 109, 1979. 6 Miller AB, Bulbrook RD: The epidemiology and etiology of breast cancer. N Engl J Med 303: 1246– 1248, 1980. 7 Anderson DE: Some characteristics of familial breast cancer. Cancer 28: 1500– 1504, 1971. 8 Lilienfeld AM: The epidemiology of breast cancer. Cancer Res 23: 1503– 1513, 1963. 9 Petrakis NL: Genetic factors in the etiology of breast cancer. Cancer 39: 2709– 2715, 1977. 10 Slaber EJ, Trichopoulos D, MacMahon B: Lactation and reproductive histories of breast cancer patients in Boston, 1965–1966. JNCI 43: 1013– 1024, 1969. 11 Wynder EL, Bross IDJ, Hirayama T: A study of the epidemiology of cancer of the breast. Cancer 13: 559– 601, 1960. 12 Staszewski J: Age at menarche and breast cancer. JNCI 47: 935– 940, 1971. 13 Trichopoulos D, MacMahon B, Cole P: Menopause and breast cancer risk. JNCI 48: 605– 613, 1972. 14 Lew EA, Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32: 563– 576, 1979. 15 De Waard F: Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35: 3351– 3356, 1975. 16 De Waard F, Baanders-van Halewijn EA: A prospective study in general practice on breast cancer risk in postmenopausal women. Int J Cancer 14: 153– 160, 1974. 17 MacKenzie I: Breast cancer following multiple fluoroscopies. Br J Cancer 19: 1– 8, 1965. 18 Wanebo CK, Johnson KG, Sato H, et al: Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki. N Engl J Med 279: 667– 671, 1968. 19 Myrden JA, Hiltz JE: Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculoses. Can Med Assoc J 100: 1032– 1034, 1969. 20 Jablon S, Kato H: Studies of the mortality of A-bomb survivors: 5. Radiation dose and mortality, 1950–1970. Radiat Res 50: 649– 698, 1972. 21 McGregor DH, Land CE, Choi K, et al: Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1969. JNCI 59: 799– 811, 1977. 22 Shore RE, Hempelmann LH, Kowaluk E, et al: Breast neoplasms in women treated with x-rays for acute postpartum mastitis. JNCI 59: 813– 822, 1977. 23 Alcantara EN, Speckman EW: Diet, nutrition, and cancer. Am J Clin Nutr 29: 1035– 1047, 1976. 24 Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 627– 631, 1975. 25 Carroll KK, Gammal EB, Plunkett ER: Dietary fat and mammary cancer. Can Med Assoc J 98: 590– 594, 1968. 26 Miller AB: Role of nutrition in the etiology of breast cancer. Cancer 39: 2704– 2708, 1977. 27 Gaskill SP, McGuire WL, Osborne CK, et al: Breast cancer mortality and diet in the United States. Cancer Res 39: 3628– 3637, 1979. 28 Miller AB, Kelly A, Choi NW, et al: A study of diet and breast cancer. Am J Epidemiol 107: 499– 509, 1978. 29 Hankin JH, Rawlings V: Diet and breast cancer: a review. Am J Clin Nutr 31: 2007– 2016, 1978. 30 Graham S, Marshall J, Mettlin C, et al: Diet in the epidemiology of breast cancer. Am J Epidemiol 116: 68– 75, 1982. 31 Rosenberg L, Slone D, Shapiro S, et al: Breast cancer and alcoholic beverage consumption. Lancet 1: 267– 270, 1982. 32 Hoover R, Gray L, Cole P, et al: Menopausal estrogens and breast cancer. N Engl J Med 295: 401– 405, 1976. 33 Ross RK, Paganini-Hill A, Gerkins VR, et al: A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243: 1635– 1639, 1980. 34 Brinton LA, Hoover RN, Szklo M, et al: Menopausal estrogen use and risk of breast cancer. Cancer 47: 2517– 2522, 1981. 35 Jick H, Walker AM, Watkins RN, et al: Replacement estrogens and breast cancer. Am J Epidemiol 112: 586– 594, 1980. 36 Lubin JH, Burns PE, Blot WJ, et al: Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. JNCI 68: 211– 217, 1982. 37 Pike MC, Henderson BE, Casagrande JT, et al: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72– 76, 1981. 38 Trapido EJ: A prospective cohort study of oral contraceptives and breast cancer. JNCI 67: 1011– 1015, 1981. 39 Vessey MP, Doll R, Jones K, et al: An epidemiologic study of oral contraceptives and breast cancer. Br Med J 1: 1757– 1760, 1979. 40 Arthes FG, Sartwell PE, Lewison EF: The pill, estrogens, and the breast: epidemiologic aspects. Cancer 28: 1391– 1394, 1971. 41 Henderson BE, Powell D, Rosario I, et al: An epidemiologic study of breast cancer. JNCI 53: 609– 614, 1974. 42 Fasal E, Paffenbarger RS: Oral contraceptives as related to cancer and benign lesions of the breast. JNCI 55: 767– 773, 1975. 43 Kelsey J, Holford TR, White C, et al: Oral contraceptives and breast disease. Am J Epidemiol 107: 236– 244, 1978. 44 Vessey MP, Doll R, Sutton PM: Oral contraceptives and breast neoplasia: a retrospective study. Br Med J 3: 719– 724, 1972. 45 Paffenbarger RS, Fasal E, Simmons ME, et al: Cancer risk as related to use of oral contraceptives during fertile years. Cancer 39: 1887– 1891, 1971. 46 Lees AW, Burns PE, Grace M: Oral contraceptives and breast disease in premenopausal northern Albertan women. Int J Cancer 22: 700– 707, 1978. 47 Shore RE, Pasternak BS, Thiessen EU, et al: A case-control study of hair dye use and breast cancer. JNCI 62: 277– 283, 1979. 48 Kinlen LJ, Harris R, Garrod A, et al: Use of hair dyes by patients with breast cancer: a case-control study. Br Med J 2: 366– 368, 1977. 49 Hennekens CH, Speizer FE, Rosner B, et al: Hair dyes and human cancer, abstracted. Am J Epidemiol 108: 240– 241, 1978. 50 Shafer N, Shafer RW: Potential of carcinogenic effects of hair dyes. NY State J Med 76: 394– 396, 1976. 51 Boston Collaborative Drug Surveillance Program: Reserpine and breast cancer. Lancet 2: 669– 671, 1974. 52 Armstrong B, Stevens N, Doll R: Retrospective study of the association between use of Rauwolfia derivatives and breast cancer in English women. Lancet 2: 672– 675, 1974. 53 Heinonen OP, Shapiro S, Tuominen L, et al: Reserpine use in relation to breast cancer. Lancet 2: 675– 677, 1974. 54 Williams RR, Feinleib M, Connor RJ, et al: Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program. JNCI 61: 327– 335, 1978. 55 Laska EM, Siegel C, Meisner M, et al: Matched-pairs study of reserpine use and breast cancer. Lancet 2: 296– 300, 1975. 56 Lilienfeld AM, Chang L, Thomas DB, et al: Rauwolfia derivatives and breast cancer. Johns Hopkins Med J 139: 41– 50, 1976. 57 O'Fallon WM, Labarthe DR. Kurland LT: Rauwolfia derivatives and breast cancer: a case-control study in Olmstead County. Minnesota. Lancet 2: 292– 296, 1975. 58 Armstrong B. Skegg D, White G. et al: Rauwolfia derivatives and breast cancer in hypertensive women. Lancet 2: 8– 12, 1976. 59 Labarthe DR. O'Fallon WM: Reserpine and breast cancer: a community-based longitudinal study of 2,000 hypertensive women. JAMA 243: 2304– 2310, 1980. 60 Seidman H: Statistical and epidemiological data on cancer of the breast. New York, American Cancer Society Inc, 1979. 61 Seidman H: Screening for breast cancer in younger women: life expectancy gains and losses. CA 27: 66– 87, 1977. 62 Hammond EC: Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 54: 11– 23, 1964. 63 Hammond EC: Smoking in relation to the death rates of one million men and women. NCI Monogr 19: 127– 204, 1966. 64 Hammond EC, Garfinkel L: The influence of health on smoking habits. NCI Monogr 19: 269– 285, 1966. 65 Hammond EC, Garfinkel L: Coronary heart disease, stroke, and aortic aneurysm: factors in the etiology. Arch Environ Health 19: 167– 182, 1969. 66 Hammond EC, Garfinkel L, Seidman H, et al: “Tar” and nicotine content of cigarette smoke in relation to death rates. Environ Res 12: 263– 274, 1976. 67 Hammond EC. Selikoff IJ, Seidman H: Asbestos exposure, cigarette smoking, and death rates. Ann NY Acad Sci 330: 473– 490, 1979. 68 De Waard F, Baanders-van Halewijn EA, Huizinga J: The bimodal age distribution of patients with mammary carcinoma: evidence for existence of two types of human breast cancer. Cancer 17: 141– 151, 1964. 69 Stavraky K, Emmons S: Breast cancer in premenopausal and postmenopausal women. JNCI 53: 647– 654, 1974. 70 Wynder EL: Identification of women at high risk for breast cancer. Cancer 24: 1235– 1240, 1969. 71 Henderson BE, Pike MC, Ross RK: Epidemiology of breast cancer, in SA Feig, R Mclelland (eds): Breast Carcinoma: Current Diagnosis and Treatment. New York, Masson Publishers, 1982. Citing Literature Volume32, Issue5September/October 1982Pages 301-313 ReferencesRelatedInformation" @default.
• W2026702932 created "2016-06-24" @default.
• W2026702932 creator A5041632370 @default.
• W2026702932 creator A5045989230 @default.
• W2026702932 creator A5080701125 @default.
• W2026702932 date "1982-09-01" @default.
• W2026702932 modified "2023-10-17" @default.
• W2026702932 title "A Different Perspective on Breast Cancer Risk Factors: Some Implications of the Nonattributable Risk" @default.
• W2026702932 cites W1510492527 @default.
• W2026702932 cites W1513856053 @default.
• W2026702932 cites W1574635335 @default.
• W2026702932 cites W1649866497 @default.
• W2026702932 cites W1782153274 @default.
• W2026702932 cites W1849177923 @default.
• W2026702932 cites W1870444970 @default.
• W2026702932 cites W1886535729 @default.
• W2026702932 cites W1889044939 @default.
• W2026702932 cites W1905727046 @default.
• W2026702932 cites W1909250455 @default.
• W2026702932 cites W1931575892 @default.
• W2026702932 cites W1938618714 @default.
• W2026702932 cites W1940051259 @default.
• W2026702932 cites W1943204001 @default.
• W2026702932 cites W1954510473 @default.
• W2026702932 cites W1966104862 @default.
• W2026702932 cites W1977523857 @default.
• W2026702932 cites W1989071539 @default.
• W2026702932 cites W1995332533 @default.
• W2026702932 cites W1996950210 @default.
• W2026702932 cites W2000973055 @default.
• W2026702932 cites W2001331557 @default.
• W2026702932 cites W2006119666 @default.
• W2026702932 cites W2011853205 @default.
• W2026702932 cites W2013004955 @default.
• W2026702932 cites W2013996799 @default.
• W2026702932 cites W2017120918 @default.
• W2026702932 cites W2017561033 @default.
• W2026702932 cites W2021817333 @default.
• W2026702932 cites W2022071549 @default.
• W2026702932 cites W2022373732 @default.
• W2026702932 cites W2040617343 @default.
• W2026702932 cites W2042972875 @default.
• W2026702932 cites W2043109563 @default.
• W2026702932 cites W2048734784 @default.
• W2026702932 cites W2049047352 @default.
• W2026702932 cites W2050266344 @default.
• W2026702932 cites W2056758459 @default.
• W2026702932 cites W2058678384 @default.
• W2026702932 cites W2067253572 @default.
• W2026702932 cites W2069930757 @default.
• W2026702932 cites W2076489967 @default.
• W2026702932 cites W2080292812 @default.
• W2026702932 cites W2084447972 @default.
• W2026702932 cites W2085399985 @default.
• W2026702932 cites W2091963984 @default.
• W2026702932 cites W2120952834 @default.
• W2026702932 cites W2122624442 @default.
• W2026702932 cites W2125698299 @default.
• W2026702932 cites W2137525930 @default.
• W2026702932 cites W2158817229 @default.
• W2026702932 cites W2161387144 @default.
• W2026702932 cites W2168022861 @default.
• W2026702932 cites W2170187121 @default.
• W2026702932 cites W2241298518 @default.
• W2026702932 cites W2255333205 @default.
• W2026702932 cites W2258859489 @default.
• W2026702932 cites W2264737464 @default.
• W2026702932 cites W2276919550 @default.
• W2026702932 cites W2336959581 @default.
• W2026702932 cites W2416070090 @default.
• W2026702932 cites W2425795282 @default.
• W2026702932 cites W2561860590 @default.
• W2026702932 doi "https://doi.org/10.3322/canjclin.32.5.301" @default.
• W2026702932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6811109" @default.
• W2026702932 hasPublicationYear "1982" @default.
• W2026702932 type Work @default.
• W2026702932 sameAs 2026702932 @default.
• W2026702932 citedByCount "109" @default.
• W2026702932 countsByYear W20267029322012 @default.
• W2026702932 countsByYear W20267029322013 @default.
• W2026702932 countsByYear W20267029322015 @default.
• W2026702932 countsByYear W20267029322017 @default.
• W2026702932 countsByYear W20267029322018 @default.
• W2026702932 countsByYear W20267029322019 @default.
• W2026702932 countsByYear W20267029322020 @default.
• W2026702932 countsByYear W20267029322021 @default.
• W2026702932 countsByYear W20267029322022 @default.
• W2026702932 countsByYear W20267029322023 @default.
• W2026702932 crossrefType "journal-article" @default.
• W2026702932 hasAuthorship W2026702932A5041632370 @default.
• W2026702932 hasAuthorship W2026702932A5045989230 @default.
• W2026702932 hasAuthorship W2026702932A5080701125 @default.
• W2026702932 hasBestOaLocation W20267029321 @default.
• W2026702932 hasConcept C112930515 @default.
• W2026702932 hasConcept C121608353 @default.
• W2026702932 hasConcept C126322002 @default.
• W2026702932 hasConcept C12713177 @default.
• W2026702932 hasConcept C154945302 @default.

• next